In-Area Manufacturing report from Traxcn
It finds there are round 15 primary startups concerned with orbital manufacturing applied sciences. And it’s a market, the authors notice, formed by lengthy improvement cycles, infrastructure dependency, and excessive capital depth.
Additionally, high-value microgravity manufacturing is recognized because the “nearest-term commercialisation pathway”, whereas in-orbit meeting and infrastructure platforms signify longer-horizon industrial potentialities.
Different primary findings embody that all-time fairness funding has reached ~$397m. Capital deployment stays episodic, nonetheless, with Varda Area Industries’ $187 million Collection C accounting for 82% of 2025 funding. Such funding, from a single spherical, indicators selective investor conviction relatively than broad-based sector enlargement, Traxcn notes.
Additionally, only one acquisition has been recorded to this point and no IPOs. This means that “liquidity stays pushed by strategic consolidation relatively than demand-validated business maturity” states the report.
Funding
Whole funding has grown from round $270,000, in 2016, to $227 million in 2025.
Tracxn writes:
“The worldwide ISM ecosystem has attracted roughly $397M in all-time fairness funding throughout 22 rounds, reflecting selective relatively than broad investor participation. Capital deployment has been risky and milestone-driven, with funding peaking at $227M in 2025, largely pushed by a single mega spherical, Varda Area Industries’ $187M Collection C.”
“This focus indicators a structural shift in investor habits, the place funding is consolidating behind technically credible operators demonstrating progress towards scalable orbital manufacturing, at the same time as early-stage gamers proceed to compete for a comparatively skinny pool of exploratory capital.”
Geography
When it comes to geographical unfold, for the ISM ecosystem, the USA expectedly leads the best way.
The States account for roughly 85% ($337m) of all-time funding. The UK emerges as a “credible secondary hub”, attracting roughly 10% of all funding, together with by means of UK Area Company initiatives (see UK firms to review manufacturing superior supplies in house and Regulatory readability promised for house manufacturing of prescription drugs, for instance).
Participation from Germany and India stays “nascent” say the report’s authors. However they establish a possible for “gradual geographic broadening as home house capabilities mature”.
In-Area Manufacturing
You possibly can obtain the report from the Traxcn web site.
The total report covers firm formation traits, investor participation, geographic focus, commercialisation pathways and exit exercise.